Amylyx Pharmaceuticals Inc. (AMLX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Amylyx Pharmaceuticals In...

    NASDAQ: AMLX · Real-Time Price · USD
    13.42
    0.13 (0.98%)
    At close: Oct 03, 2025, 3:59 PM
    13.66
    1.79%
    After-hours: Oct 03, 2025, 05:51 PM EDT

    Amylyx Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 87.37M 380.79M 22.23M 285K
    Cost of Revenue
    		 124.63M 25.44M 2.99M 52K
    Gross Profit
    		 -37.26M 355.35M 19.24M 233K
    Operating Income
    		 -314.73M 38.8M -201.34M -82.69M
    Interest Income
    		 13.81M 16.16M 4.29M 36K
    Pretax Income
    		 -302.14M 54.3M -197.6M -87.93M
    Net Income
    		 -301.74M 49.27M -198.38M -87.88M
    Selling & General & Admin
    		 114.33M 188.36M 127.13M 38.93M
    Research & Development
    		 104.08M 128.19M 93.45M 44.04M
    Other Expenses
    		 141.53M n/a n/a -285K
    Operating Expenses
    		 359.95M 316.54M 220.58M 82.69M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a 9.5M 4.4M n/a
    Cost & Expenses
    		 402.1M 341.98M 223.57M 82.69M
    Income Tax Expense
    		 -393K 5.03M 774K -52K
    Shares Outstanding (Basic)
    		 68.14M 67.23M 66.51M 57.86M
    Shares Outstanding (Diluted)
    		 68.14M 69.99M 66.51M 57.86M
    EPS (Basic)
    		 -4.43 0.73 -2.98 -1.52
    EPS (Diluted)
    		 -4.43 0.70 -2.98 -1.52
    EBITDA
    		 -290.98M 39.89M -200.85M -82.64M
    EBIT
    		 -291.88M 38.8M -201.34M -82.69M
    Depreciation & Amortization
    		 904K 1.09M 487K 52K

    Add to Watchlist